Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2

Abstract The low proportion of gastric cancer (GC) patients with high HER2 expression limits the clinical application of trastuzumab, a humanized epidermal growth factor receptor 2 (HER2) antibody targeting for GC treatment. We found that Dicer was positively correlated with HER2 expression in GC ti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jianhua Wu, Qun Zhao, Yue Zhao, Xiaoyun Zhang, Yuan Tian, Zhanjun Guo
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b3bcd3fb5f7b40a9b8fd47887dba0eb0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!